Stocks · Health care · Pharmaceutical Preparations

Viatris

VTRS Clue Score21
United States Fiscal year ends December CIK 0001792044 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Paul Campbell
25 Jun 2026
See Remarks
Sold on a plan
50,076
$16.17
$809.78K
Goff Corinne Le
11 Sep 2025
Chief Commercial Officer
Sold on a plan
7,032
$10.25
$72.04K
Dillon JoEllen Lyons
5 Mar 2024
Director
Sold on a plan
20,000
$12.36
$247.20K
Andrew Cuneo
23 Feb 2024
See Remarks
Sold on a plan
4,000
$13.50
$54.00K
Andrew Cuneo
15 Feb 2024
See Remarks
Sold on a plan
4,000
$12.50
$50.00K
Andrew Cuneo
4 Jan 2024
See Remarks
Sold on a plan
4,000
$11.50
$46.00K
Andrew Cuneo
14 Dec 2023
See Remarks
Sold on a plan
4,000
$10.50
$42.00K

What was left out

Form 4 filings counted 280
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 1,394,932,371
Sales filed before the plan box existed 8
History held since 16 Nov 2020